NIAID Funding News


NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. You can subscribe directly by entering your email address at Email Updates and then selecting your subscription topics. Visit Stay Informed About Policy Changes and News for more opportunities to connect with us.

When an application spans multiple institutes' research priorities, NIH's Center for Scientific Review designates one institute as primary and the other(s) as secondary.

NIAID researcher reaching for cell cultures in a CO2 incubator

Opportunities and Resources

Help advance the experimental validation and functional characterization of genetic variants in genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases.

NIAID will support research projects on celiac disease pathogenesis, including pathways of disease and tissue destruction, and the cause of intolerance to a component of food.

Coordinate and accelerate tuberculosis (TB) and TB/HIV research across all of the RePORT national networks and foster a synergistic approach among them. 

In The News

CDC added the following to the list of HHS select agents: SARS-CoV/SARS-CoV-2 chimeras in which SARS-CoV (already a select agent) virulence factors have been inserted into SARS-CoV-2 (not a select agent).

You can access videos, slide sets, and transcripts from dozens of seminar session presentations from the 2021 NIH Virtual Seminar on Program Funding and Grants Administration.

Advice Corner

As an applicant or a funded investigator, there’s a good chance you’ll need guidance on administrative or fiscal issues related to your grant or award. Whom should you call for help?

Contact Us

Email us at for help navigating NIAID’s grant and contract policies and procedures.